Literature DB >> 21766084

Long-term survival in idiopathic pulmonary arterial hypertension associated with massive pulmonary artery dilation.

Vanja Petrovic1, Christopher J Ryerson, Robert D Levy.   

Abstract

The present report describes two patients with long-term survival after being diagnosed with idiopathic pulmonary arterial hypertension more than 20 years earlier. Both patients were treated with calcium channel blockers for several years and are currently maintained on bosentan, an oral endothelin receptor antagonist. Severe dilation of the main pulmonary arteries is present in both patients and may be related to long-term survival with idiopathic pulmonary arterial hypertension.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21766084      PMCID： PMC3328880          DOI： 10.1155/2011/710489

Source DB:  PubMed          Journal:  Can Respir J        ISSN： 1198-2241            Impact factor:   2.409


  9 in total

1.  Relationship of pulmonary arterial capacitance and mortality in idiopathic pulmonary arterial hypertension.

Authors:  Srijoy Mahapatra; Rick A Nishimura; Paul Sorajja; Stephen Cha; Michael D McGoon
Journal:  J Am Coll Cardiol       Date:  2006-01-26       Impact factor: 24.094

Review 2.  Updated clinical classification of pulmonary hypertension.

Authors:  Gérald Simonneau; Ivan M Robbins; Maurice Beghetti; Richard N Channick; Marion Delcroix; Christopher P Denton; C Gregory Elliott; Sean P Gaine; Mark T Gladwin; Zhi-Cheng Jing; Michael J Krowka; David Langleben; Norifumi Nakanishi; Rogério Souza
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

3.  Benign, idiopathic pulmonary hypertension? Two further cases of unusually long duration.

Authors:  E Trell
Journal:  Acta Med Scand       Date:  1973 Jan-Feb

4.  Primary pulmonary hypertension. Case series from the United Kingdom.

Authors:  C W Oakley
Journal:  Chest       Date:  1994-02       Impact factor: 9.410

5.  The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension.

Authors:  S Rich; E Kaufmann; P S Levy
Journal:  N Engl J Med       Date:  1992-07-09       Impact factor: 91.245

6.  Long term survival in primary pulmonary hypertension.

Authors:  M Halank; C Marx; G Hoeffken
Journal:  Heart       Date:  2004-07       Impact factor: 5.994

Review 7.  Genetics of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd; John A Phillips
Journal:  Semin Respir Crit Care Med       Date:  2009-07-24       Impact factor: 3.119

8.  Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

Authors:  G E D'Alonzo; R J Barst; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; J T Kernis
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

9.  Primary pulmonary hypertension. A national prospective study.

Authors:  S Rich; D R Dantzker; S M Ayres; E H Bergofsky; B H Brundage; K M Detre; A P Fishman; R M Goldring; B M Groves; S K Koerner
Journal:  Ann Intern Med       Date:  1987-08       Impact factor: 25.391
  9 in total
  1 in total

1.  Pulmonary artery enlargement in schistosomiasis associated pulmonary arterial hypertension.

Authors:  Susana Hoette; Claudia Figueiredo; Bruno Dias; Jose Leonidas Alves; Francisca Gavilanes; Luis Felipe Prada; Dany Jasinowodolinski; Luciana Tamie Kato Morinaga; Carlos Jardim; Caio Julio Cesar Fernandes; Rogério Souza
Journal:  BMC Pulm Med       Date:  2015-10-12       Impact factor: 3.317
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.